tooyes glp-1 supplement reviews and complaints In the gray world of supplements online, health experts urge caution 💉 The truth about GLP-1

A study in July 2024 by researchers at Mass Eye and Ear in Boston found that people taking semaglutide for type 2 diabetes or weight loss had a higher risk of developing nonarteritic anterior ischemic optic neuropathy, an eye condition that can cause blindness, than people taking medications other than GLP-1 drugs for diabetes or obesity

Legally, the situation becomes more complicated and depends largely on whether you are the one purchasing or distributing the drug

If a patient is consistently losing a healthy amount of weight and feels well, the patients clinician may elect to establish the current dose as meeting the patients needs rather than force an increase for protocols sake

As patients progress through treatment, they often notice benefits that extend beyond the scale